GENOMATCH.ME Trademark

Trademark Overview

On Monday, September 18, 2017, a trademark application was filed for GENOMATCH.ME with the United States Patent and Trademark Office. The USPTO has given the GENOMATCH.ME trademark a serial number of 87612369. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 19, 2025. This trademark is owned by Diagnomics Inc.. The GENOMATCH.ME trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Structural and functional analysis of genomes; Genome amplification services; Providing laboratory research services in the field of individual gene expression based on analysis of individual patients' genome
genomatch.me

General Information

Serial Number87612369
Word MarkGENOMATCH.ME
Filing DateMonday, September 18, 2017
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 19, 2025
Registration Number5770443
Registration DateTuesday, June 4, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 27, 2018

Trademark Statements

Pseudo MarkGENO MATCH ME
Goods and ServicesStructural and functional analysis of genomes; Genome amplification services; Providing laboratory research services in the field of individual gene expression based on analysis of individual patients' genome

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 19, 2025
Primary Code042
First Use Anywhere DateMonday, October 1, 2018
First Use In Commerce DateMonday, October 1, 2018

Trademark Owner History

Party NameDiagnomics Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92123
Party NameDiagnomics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92123
Party NameDiagnomics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92123

Trademark Events

Event DateEvent Description
Thursday, September 21, 2017NEW APPLICATION ENTERED
Friday, September 22, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 21, 2017ASSIGNED TO EXAMINER
Friday, December 22, 2017NON-FINAL ACTION WRITTEN
Friday, December 22, 2017NON-FINAL ACTION E-MAILED
Friday, December 22, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 5, 2018EXAMINERS AMENDMENT -WRITTEN
Friday, January 5, 2018EXAMINERS AMENDMENT E-MAILED
Friday, January 5, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, January 5, 2018EXAMINER'S AMENDMENT ENTERED
Monday, January 8, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 19, 2018ASSIGNED TO LIE
Wednesday, February 7, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 27, 2018PUBLISHED FOR OPPOSITION
Tuesday, February 27, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 24, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, October 11, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 12, 2018SOU TEAS EXTENSION RECEIVED
Friday, October 12, 2018SOU EXTENSION 1 FILED
Friday, October 12, 2018SOU EXTENSION 1 GRANTED
Tuesday, October 16, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 18, 2019TEAS STATEMENT OF USE RECEIVED
Wednesday, May 1, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, April 18, 2019USE AMENDMENT FILED
Wednesday, May 1, 2019STATEMENT OF USE PROCESSING COMPLETE
Wednesday, May 1, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, May 2, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 4, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, June 4, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, December 19, 2025CANCELLED SEC. 8 (6-YR)

Related Keywords

genomatch individual services genome analysis gene patients expression field based providing